Cite
Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.
MLA
Abdelbary, Ghada Ahmed, and Mina Ibrahim Tadros. “Brain Targeting of Olanzapine via Intranasal Delivery of Core-Shell Difunctional Block Copolymer Mixed Nanomicellar Carriers: In Vitro Characterization, Ex Vivo Estimation of Nasal Toxicity and in Vivo Biodistribution Studies.” International Journal of Pharmaceutics, vol. 452, no. 1–2, Aug. 2013, pp. 300–10. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2013.04.084.
APA
Abdelbary, G. A., & Tadros, M. I. (2013). Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies. International Journal of Pharmaceutics, 452(1–2), 300–310. https://doi.org/10.1016/j.ijpharm.2013.04.084
Chicago
Abdelbary, Ghada Ahmed, and Mina Ibrahim Tadros. 2013. “Brain Targeting of Olanzapine via Intranasal Delivery of Core-Shell Difunctional Block Copolymer Mixed Nanomicellar Carriers: In Vitro Characterization, Ex Vivo Estimation of Nasal Toxicity and in Vivo Biodistribution Studies.” International Journal of Pharmaceutics 452 (1–2): 300–310. doi:10.1016/j.ijpharm.2013.04.084.